ViralVacDB | Details of Viral Vaccine

Respiratory Syncytial Virus Infection

Respiratory syncytial virus (RSV) is the most important cause of acute lower respiratory tract infection in young children worldwide. It also is responsible for substantial morbidity and mortality in the elderly and in severely immunocompromised individuals. HRSV infections are considered highly contagious, affecting nearly 70% of infants before the first year of life and nearly 100% of children by the age of 2.11 Worldwide, approximately 34 million new cases of hRSV-associated ALRTI occur in children younger than 5 years and as much as 200,000 deaths are estimated annually
Detailed Information
Disease Name Respiratory Syncytial Virus Infection
Virus Name Human respiratory syncytial virus
Capsid Symmetry Helical
Capsid Naked/Enveloped Enveloped
Family Pneumoviridae
Genus Orthopneumovirus
Genome Negative-sense, single-stranded RNA
Proteome RSV encodes 11 separate proteins
Antigenic Target G protein
Incubation Period 2 to 8 days, 4 to 6 days is most common
Zoonotic Evidence No
Host Human
Chronology_Time 1956
Regions Affected Belgium, United Kingdom, Japan, and North America
Susceptible Age Group Infants less than 2 years
Transmission Route Respiratory
Symptoms Congested or runny nose, Dry cough, Low-grade fever, Sore throat, Sneezing, Headache
Co-infection NA
Genome Reference Genome Link
Proteome Reference Proteome Link
Reference Reference